PRESS RELEASE published on 05/24/2024 at 09:00, 2 years 5 months ago Eckert & Ziegler receives “Best Managed Companies Award” Eckert & Ziegler SE has been awarded the 'Best Managed Companies Award' by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries for outstanding management in strategy, productivity, innovation, culture, and finance Corporate Strategy Eckert & Ziegler SE Medium-Sized Companies Best Managed Companies Award Deloitte Private
BRIEF published on 05/14/2024 at 07:55, 2 years 5 months ago Eckert & Ziegler Reports Strong Q1 2024 Financial Growth Financial Growth Q1 2024 Earnings Eckert & Ziegler SE Sales Forecast 2024 Medical Segment Sales
PRESS RELEASE published on 05/14/2024 at 07:50, 2 years 5 months ago Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed. Eckert & Ziegler SE reports strong Q1 results with 17% sales increase and 41% rise in adjusted EBIT. Forecast for 2024 confirmed. Read more: https://www.ezag.com/fileadmin/user_upload/ezag/investors-financial-reports/englisch/euz124e.pdf Adjusted EBIT Sales Increase 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF published on 04/22/2024 at 14:54, 2 years 6 months ago Eckert & Ziegler: Boost in Q1 Sales and Earnings, 2024 Forecasts Unchanged Sales Increase 2024 Forecast EBIT Growth Eckert & Ziegler SE Q1 Financial Results
PRESS RELEASE published on 04/22/2024 at 14:49, 2 years 6 months ago EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed. Eckert & Ziegler SE reports strong Q1 results with sales of EUR 67.6 million and net income of EUR 8.5 million. 2024 annual forecast confirmed Sales Earnings 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF published on 03/22/2024 at 07:50, 2 years 7 months ago Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023 2023 Financial Year Eckert & Ziegler Annual Results Financial Growth Radiopharmaceuticals
PRESS RELEASE published on 03/22/2024 at 07:45, 2 years 7 months ago Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023 Eckert & Ziegler SE reports sales growth in 2023 financial year, with sales reaching €246.1 million. Expecting sales of nearly €265 million in 2024 Sales Growth EBIT Financial Year 2023 Eckert & Ziegler SE Radiopharmaceuticals
BRIEF published on 03/21/2024 at 10:05, 2 years 7 months ago Eckert & Ziegler Achieves Key Milestone with MDR Certification for Prostate Seeds Eckert & Ziegler Patient Safety MDR Certification Prostate Seeds Brachytherapy
PRESS RELEASE published on 03/21/2024 at 10:00, 2 years 7 months ago Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy
BRIEF published on 03/19/2024 at 19:51, 2 years 7 months ago Eckert & Ziegler Announces Dividend Cut to Fund Future Investments Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
Published on 10/30/2026 at 23:35, 23 hours 50 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 23 hours 55 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 4 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 7 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 6 hours 50 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 4 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 11 hours ago Capital increase through exercise of subscription rights